Processa Pharmaceuticals (PCSA) Gross Profit (2012 - 2016)
Processa Pharmaceuticals' (PCSA) quarterly Gross Profit came in at $5000.0 in Q1 2016, down 60.92% YoY from $12794.0 in Q2 2015, and up 112.26% on a QoQ basis from -$40792.0 in Q4 2015.
Processa Pharmaceuticals (PCSA) Gross Profit (2012 - 2016) Analysis & Trends
Processa Pharmaceuticals (PCSA) has 5 years of Gross Profit data on file, last reported at $5000.0 in Q1 2016.
- Quarterly Gross Profit fell 60.92% year-over-year to $5000.0 in Q1 2016, while the trailing twelve-month figure through Dec 2016 was $5000.0 (up 246.28% YoY) and the FY2016 annual result came in at $5000.0, up 140.16% from the prior year.
- Gross Profit grew to $5000.0 in Q1 2016, from -$40792.0 in the prior quarter.
- In the past five years, Gross Profit ranged from a high of $45460.0 in Q3 2013 to a low of -$40792.0 in Q4 2015.
- A 5-year average of $13946.7 and a median of $13968.0 in 2012 frame the typical range for Gross Profit.
- Annual changes were most pronounced in 2013 — Gross Profit soared 2286.59% — and 2014, when it tumbled 212.67%.
- Tracing PCSA's Gross Profit over 5 years: stood at -$1655.0 in 2012, then soared by 2286.59% to $36188.0 in 2013, then plunged by 212.67% to -$40774.0 in 2014, then slipped by 0.04% to -$40792.0 in 2015, then surged by 112.26% to $5000.0 in 2016.
- The last three Gross Profit figures came in at $5000.0 (Q1 2016), -$40792.0 (Q4 2015), and $15547.0 (Q3 2015), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Processa Pharmaceuticals | 5.93 Mn | 5.93 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2016 | 5,000.00 |
| Mar 31, 2016 | 5,000.00 |
| Dec 31, 2015 | -40,792.00 |
| Dec 31, 2015 | -40,792.00 |
| Sep 30, 2015 | 15,547.00 |
| Sep 30, 2015 | 15,547.00 |
| Jun 30, 2015 | 9,033.00 |
| Jun 30, 2015 | 9,033.00 |
| Mar 31, 2015 | 12,794.00 |
| Mar 31, 2015 | 12,794.00 |
| Dec 31, 2014 | -40,774.00 |
| Dec 31, 2014 | -40,774.00 |
| Sep 30, 2014 | 27,332.00 |
| Sep 30, 2014 | 27,332.00 |
| Jun 30, 2014 | 42,643.00 |
| Jun 30, 2014 | 42,643.00 |
| Mar 31, 2014 | 11,205.00 |
| Mar 31, 2014 | 11,205.00 |
| Dec 31, 2013 | 36,188.00 |
| Dec 31, 2013 | 36,188.00 |